Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma

BJU International

Volumn 113, Issue 4, 2014, Pages 668-673

  Gayed, Bishoy A ^a   Youssef, Ramy F ^a   Bagrodia, Aditya ^a   Darwish, Oussama M ^a   Kapur, Payal ^a   Sagalowsky, Arthur ^a   Lotan, Yair ^a   Margulis, Vitaly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

biological markers; Ki67 antigen; RCC; renal cell carcinoma

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ANTIGEN DETECTION; ANTIGEN RETRIEVAL; ARTICLE; CANCER LOCALIZATION; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; VERY ELDERLY;

BIOLOGICAL MARKERS; KI67 ANTIGEN; RCC; RENAL CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; YOUNG ADULT;

EID: 84896391330     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12263     Document Type: Article

References (25)

1. Visapää H, Bui M, Huang Y, et al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 2003; 61: 845-850
2. Hernandez-Yanez M, Heymach JV, Zurita AJ,. Circulating biomarkers in advanced renal cell carcinoma: clinical applications. Curr Oncol Rep 2012; 14: 221-229
3. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H,. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715
4. Gerdes J,. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990; 1: 199-206
5. Tollefson MK, Thompson RH, Sheinin Y, et al. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer 2007; 110: 783-790
6. Rioux-Leclercq N, Turlin B, Bansard J, et al. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 2000; 55: 501-505
7. Dudderidge TJ, Stoeber K, Loddo M, et al. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 2005; 11: 2510-2517
8. Fuhrman SA, Lasky LC, Limas C,. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-663
9. Eble JN,. World Health Organization: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004
10. Edge SB, Byrd DR, Comptom CC, et al. AJCC Staging Manual, 7th edn. Philadelphia, PA: Springer, 2009
11. Klatte T, Seligson DB, LaRochelle J, et al. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev 2009; 18: 894-900
12. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H,. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168: 2395-2400
13. Jonat W, Arnold N,. Is the Ki-67 labelling index ready for clinical use? Ann Oncol 2011; 22: 500-502
14. Wirapati P, Sotiriou C, Kunkel S, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008; 10: R65
15. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ,. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009; 20: 1319-1329
16. Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM, Brennan MF,. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer 1998; 83: 490-497
17. Zini L, Porpiglia F, Fassnacht M,. Contemporary management of adrenocortical carcinoma. Eur Urol 2011; 60: 1055-1065
18. Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y,. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clin Cancer Res 2006; 12: 7369-7373
19. Margulis V, Lotan Y, Karakiewicz PI, et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst 2009; 101: 114-119
20. de Riese WT, Crabtree WN, Allhoff EP, et al. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J Clin Oncol 1993; 11: 1804-1808
21. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S,. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer [Research Support, Non-U.S. Gov't] 1991; 67: 421-428
22. Hofmockel G, Tsatalpas P, Muller H, et al. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer 1995; 76: 296-306
23. Parker AS, Leibovich BC, Lohse CM, et al. Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer [Evaluation Studies]. 2009; 115: 2092-2103
24. Kramer BA, Gao X, Davis M, Hall M, Holzbeierlein J, Tawfik O,. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma. J Am Coll Surg 2005; 201: 565-570
25. Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY,. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int 2004; 93: 1087-1093